- Antitrust analysis
- Competitive effects
- Healthcare economics
- Industrial organization
- Pharmaceutical economics
- Public policy
- Health insurance
- Physician groups
Leemore S. Dafny, PhD
- Academic Affiliate
- For contact information, please see below
Leemore Dafny is a tenured economist at the Harvard Business School, where she holds the position of MBA Class of 1960 Professor of Business Administration. She is also a Member of the Faculty of the John F. Kennedy School of Government. Prior to joining Harvard, she was Professor of Strategy, the Herman Smith Research Professor in Hospital and Health Services, and the Director of Health Enterprise Management at Northwestern University’s Kellogg School of Management. Dr. Dafny is a Research Associate of the National Bureau of Economic Research, a Board member of the American Society of Health Economists and the Health Care Cost Institute, and a member of the Panel of Health Advisers to the Congressional Budget Office.
In 2012–2013, Dr. Dafny served as Deputy Director for Health Care and Antitrust at the Federal Trade Commission’s Bureau of Economics, a newly created position designed to enhance the agency’s efforts to promote competition in the healthcare sector. In her FTC role, Dr. Dafny oversaw a staff of more than 50 economists, investigating cases and advising on competitive issues ranging from effects of provider consolidation to reverse payment settlements in the pharmaceutical industry. Dr. Dafny has been retained in several healthcare matters, including both provider and insurer mergers. She has also submitted public comments and amicus briefs in several cases.
Dr. Dafny’s academic research focuses on competitive interactions among payers and providers of healthcare services, with an emphasis on antitrust, competitive strategy, and public policy. Notably, Dr. Dafny’s research on health insurance markets was instrumental to policymakers as they developed institutions and policies central to President Obama’s healthcare reform law. Her work has been published in leading journals including the American Economic Review and the New England Journal of Medicine (NEJM), and featured in outlets such as the New York Times and the Washington Post. Dr. Dafny has won numerous awards for her MBA teaching and advises doctoral dissertations. She also serves as editor or associate editor of three academic journals, and is the lead advisor for the “New Marketplace” segment of NEJM Catalyst, a multimedia platform devoted to the exchange of ideas for improving healthcare. Dr. Dafny recently testified before the Senate Subcommittee on Antitrust, Competition Policy, and Consumer Rights on the impact of health insurance consolidation on consumers.
- Submitted expert report and provided deposition testimony on monopoly power, monopsony power, and exclusionary conduct on behalf of a hospital system in its antitrust suit.
- Working on behalf of the Federal Trade Commission, analyzed the competitive effects of a Texas Medical Board rule requiring that physicians meet face to face with patients before offering certain services such as prescribing medication via telemedicine. The FTC closed its investigation after the State of Texas enacted a law that overrode the Texas Medical Board’s restrictive rules.
- New England Journal of Medicine, October 12, 2016
- March 18, 2016
- University of Calgary: SPP Research Papers, December 2009
- Washington, DC (Bates White Office), November 24, 2014
- Boston, MA, September 29, 2014